SYNPROMICS LTD
Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations. The company was founded in 2010 and is based in Edinburgh, United Kingdom.
SYNPROMICS LTD
Industry:
Biotechnology Genetics Health Care Medical Therapeutics
Founded:
2010-01-01
Address:
Edinburgh, Edinburgh, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.synpromics.com
Total Employee:
1+
Status:
Closed
Contact:
+4401316585301
Email Addresses:
[email protected]
Total Funding:
9.2 M GBP
Technology used in webpage:
Domain Not Resolving SPF Amazon Twitter Tweet Button Facebook Like Button Amazon Ohio Region Google Plus One Platform Google Plus One Button NameBright LinkedIn Share Plugin
Current Employees Featured
Founder
Investors List
Scottish Enterprise
Scottish Enterprise investment in Grant - Synpromics Ltd
Calculus Capital
Calculus Capital investment in Venture Round - Synpromics Ltd
Scottish Investment Bank
Scottish Investment Bank investment in Venture Round - Synpromics Ltd
Calculus Capital
Calculus Capital investment in Venture Round - Synpromics Ltd
Scottish Enterprise
Scottish Enterprise investment in Venture Round - Synpromics Ltd
Official Site Inspections
http://www.synpromics.com Semrush global rank: 3.89 M Semrush visits lastest month: 2.93 K
Unable to get host informations!!!
More informations about "Synpromics Ltd"
Synpromics Synthetic Promoters for Gene Control - AskBio
AskBio acquired Synpromics Ltd, a leader in gene control synthetic promoter technology, in August 2019. Based on a proprietary data-driven design and bioinformatics, AskBio’s synthetic …See details»
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy …
Aug 13, 2019 About Synpromics. Synpromics is the leader in gene control, improving human health by enabling safer, more effective cell and gene medicines through proprietary …See details»
Synpromics Company Profile 2024: Valuation, Investors
Synpromics General Information Description. Developer of gene control designed to improve human health by enabling safer, more effective cell and gene medicines through proprietary …See details»
Synpromics Ltd - LinkedIn
Synpromics is the leader in gene control, improving human health by enabling safer, more effective cell and gene medicines through proprietary genomics, bioinformatics and intelligent …See details»
Synpromics - Products, Competitors, Financials, Employees, …
Synpromics develops synthetic gene promoters, which are vital components in the research and development of gene-based medical treatments and therapies. Synpromics gives biological …See details»
Synpromics Ltd acquired by Asklepios BioPharmaceutical
Aug 13, 2019 Synpromics Ltd Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations. Acquiring Organization: Asklepios …See details»
Synpromics Ltd - Funding, Financials, Valuation & Investors
Synpromics develops and commercializes synthetic promoters to control gene expressions and regulations. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Synpromics Ltd | UK Technology Fast 50 | Deloitte UK
Synpromics’ license fees are structured in upfront fees, milestones and royalties, and this revenue will be paid in over the coming decade. Founded by Michael Roberts, a noted biochemist, in 2010, Synpromics was originally focused on …See details»
Synpromics Ltd - Gene Therapy Review
Nov 22, 2015 Synpromics is a Biotech company incorporated with a view to develop a series of synthetic promoters that can be used to control genes under a variety of settings. It is envisaged that the products produced by Synpromics …See details»
Synpromics - Company Profile - Tracxn
5 days ago Synpromics Awarded Innovate UK Grant To Evaluate Its Inducible Promoter Platform In Collaboration With Lonza Pharma & BiotechGlobal Pharma Update • Apr 23, 2018 • …See details»
Synpromics Company Profile - Office Locations, Competitors
Synpromics £1.2 m in annual revenue in FY 2018. See insights on Synpromics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Synpromics Ltd - VentureRadar
Synpromics is a company incorporated with a view to develop a series of synthetic promoters that can be used to control genes under a variety of settings. VentureRadar Research / Company …See details»
AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy …
Aug 19, 2019 more precise cell targeting and gene expression. Synpromics will operate as a wholly owned subsidiary and remain headquartered in Edinburgh, United Kingdom. “By …See details»
Synpromics - Synthetic Biology Companies UK | Partners
Synpromics was founded to commercialise proprietary and patent-pending technology, developed by Dr Michael Roberts, in the emerging field of synthetic biology. Synpromics gives biological …See details»
RhiaPharmaceutical Acquires Synpromics Ltd. and Expands its …
Aug 13, 2019 Research Triangle Park, N.C. (Aug. 13, 2019) – RhiaPharmaceutical, the world’s foremost clinical stage and gene therapy platform company, has acquired Synpromics, the …See details»
Synpromics deal significantly exceeds returns for investors …
Aug 13, 2019 The success of the Synpromics sale comes as Calculus, which created the UK’s first approved EIS Fund in 1999, celebrates its 20-year anniversary by unveiling its new Fund …See details»
Synpromics Ltd - Contacts, Employees, Board Members
Organization. Synpromics Ltd . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Highlights. Employee Profiles 3. About. Synpromics Ltd has 3 …See details»
Synpromics - SynbiCITE
Synpromics Creating a Custom Synthetic Promoters Company. People also read. CHAIN Biotechnology. Building a Clostridia technology company. Prokarium . Producing Oral …See details»
Synpromics CEO and Key Executive Team | Craft.co
Synpromics's President is David Venables. Other executives include Sheila Mikhail, Chief Executive Officer and Co-Founder; Ken Macnamara, Chief Operating Officer and 8 others. …See details»